Comparative Effectiveness of Dexamethasone in Treatment of Hospitalized COVID-19 Patients during the First Year of the Pandemic: The N3C Data Repository.

Richard Zhou Kaitlyn E Johnson Justin F Rousseau Paul J Rathouznull null

Published in: medRxiv : the preprint server for health sciences (2022)

We add evidence that dexamethasone provides benefit with respect to mortality and severe outcomes in a diverse, national hospitalized sample, prior to vaccine availability.

Keyphrases

sars cov
high dose
low dose
coronavirus disease
electronic health record
quality improvement
cardiovascular events
early onset
risk factors
cardiovascular disease
type diabetes
skeletal muscle
metabolic syndrome
coronary artery disease
drug induced
deep learning
weight loss
artificial intelligence